The results showed that for males with ALT ≤40 U/L, the morbidity rate of MetS was 25.81%; of which, the morbidity rate in the first (1–14 U/L), second (15–19 U/L), third (20–25 U/L), and fourth groups (26–40 U/L) was 14.29%, 22.73%, 20.61%, and 45.14%, respectively. Here, GPT is linked to metabolic syndrome.